Alec has collaborated extensively with global life sciences innovators, leading strategic engagements across product and organizational life cycles. While Alec has tackled a diverse range of business problems, areas of particular focus include platform growth strategy, corporate strategy (asset and therapeutic area), and business development, both for biopharma and investors. In that context, Alec has deep experience across major therapeutic areas, with recent emphasis in neurology, oncology/hematology, orphan diseases, and immunology. When partnering with clients, Alec strives to bridge technical/clinical perspectives to clear business implications for organizations, and articulate realistic paths forward.
Alec has 6+ years of experience in life sciences consulting and research. Alec holds an MBA from MIT Sloan and B.A.s in Neuroscience and Economics from Dartmouth College.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson